Arena Pharmaceuticals, Inc. and Beacon Discovery have entered into a strategic multi-year partnership (Project Cabrillo) aimed at developing novel medicines across a range of G protein-coupled receptor (GPCR) targets.   Beacon will be responsible for drug discovery activities and Arena will focus on developing and commercializing promising compounds for a variety of immune and inflammatory diseases that complement their first- or best-in-class pipeline. Financial terms were not disclosed. &...